Perth-based burns treatment developer Clinical Cell Culture Ltd has closed its $10 million share purchase plan oversubscribed, as well as raising $3.8 million in a placement, to raise funds for further growth, the company announced today.

Perth-based burns treatment developer Clinical Cell Culture Ltd has closed its $10 million share purchase plan oversubscribed, as well as raising $3.8 million in a placement, to raise funds for further growth, the company announced today.